By Jessica Corso ( October 8, 2014, 5:12 PM EDT) -- Apotex Inc. has petitioned the Federal Circuit for an en banc rehearing on its decision to invalidate a high blood pressure drug patent, saying Apotex's founder didn't have to reveal prior art that was never made publicly available....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.